Islatravir/Ulonivirine

N/A

Report date: 2026/05/13 20:02:10

Base Information

Drug NameIslatravir/Ulonivirine
Drug Alias NameMK-8591B
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitorsNon-nucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitors
TargetsNucleotide reverse transcriptaseHuman immunodeficiency virus type 1 reverse transcriptase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesMexico +[9] 
CombinationsYes UlonivirineIslatravir
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme CorpMerck Sharp & Dohme LLC
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A